Swiss Biotech Startup ALP Bio Secures €161,000 From Venture Kick for Drug Safety Platform
Swiss biotech startup ALP Bio has secured €161,000 from Venture Kick to develop a platform combining human immune tissue models and AI to predict immune-related risks in biologic drug development, improving safety and success rates.